Postoperative pathology suggested pituitary metastasis, and the next-generation gene sequencing conducted on the pituitary metastasis indicated that secondary drug resistance mutation ALK-I1171s occurred after the ALK fusion gene.<h4>Conclusion</h4>In this article, we present a patient with suspected pituitary metastases with lung cancer. Here, ALK is linked to lung cancer.